John Meijer

2.4k citations

29 papers · 1.9k indexed · 1 hit paper · h-index 18

Impact in

Biological Psychiatry top 2%
- Tryptophan and brain disorders
Urology top 2%
- Urinary Bladder and Prostate Research

Papers in

Urology 10
- Urinary Bladder and Prostate Research 10
Endocrinology, Diabetes and Metabolism 12
- Hormonal and reproductive studies 8

Co-authors: Amanda J. Kiliaan Monique M.B. Breteler Albert Hofman Henning Tiemeier Annemieke Ruitenberg Marianne J. Engelhart John C. van Swieten Jacqueline C.M. Witteman
Journals: Bioanalysis (2 papers)Brain Research (1 paper)Journal of Affective Disorders (1 paper)Therapeutic Drug Monitoring (1 paper)Advances in Therapy (1 paper)
Partner nations: Netherlands United States Japan

In The Last Decade

John Meijer

28 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. 2004 · 603 citations

Peers

Countries citing papers authored by John Meijer

Since Specialization

Citations

This map shows the geographic impact of John Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Meijer more than expected).

Fields of papers citing papers by John Meijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Meijer. The network helps show where John Meijer may publish in the future.

Co-authors

The 25 scholars most cited alongside John Meijer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Meijer Line = papers co-authored together John Meijer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects Advances in Therapy ·А.П. БРЫСЕВ, 沈志辉, Ingrid Michon, P. T. Carter, Y S Sohn, John Meijer, Matthias Stoelzel, Yuichiro Sato	2020	1
2	Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity Pharmacology Research & Perspectives ·Stacey Tannenbaum, Nhung Truong, Walter Krauwinkel, John Meijer, N. Supakata, Eamon Huges, Donald Newgreen	2020	3
3	Validation of LC–MS/MS methods for the determination of mirabegron and eight metabolites in human plasma in a paediatric population Journal of Pharmaceutical and Biomedical Analysis ·John Meijer, Yeonjun In, C. Wang, A. S. Pereira, Nurhamizah Rahmat, Stephen H. F Dowall, Walter Krauwinkel	2019	15
4	Determination of methionine-enkephalin and leucine-enkephalin by LC-MS in human plasma: Study of pre-analytical stability Analytical Biochemistry ·Kenia Teresa González López Trigo, Begoña Barroso, John Meijer, Stephen H. F Dowall	2018	7
5	Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives European Journal of Drug Metabolism and Pharmacokinetics ·Teodora Ristariu, Jan van Dijk, Walter Krauwinkel, Shino Nakanishi, John Meijer, Reiner Tretter, Wenhui Zhang, Marcel van Gelderen	2016	15
6	Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men International Journal of Clinical Pharmacology and Therapeutics ·Marcel van Gelderen, Reiner Tretter, John Meijer, Caroline A. Dorrepaal, R.S. Kamalakar, Ashley Brooks, Walter Krauwinkel, James Dickinson	2014	19
7	Evaluation of the Pharmacokinetic Interaction Between the β₃‐Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects Clinical Pharmacology in Drug Development ·Walter Krauwinkel, Shino Nakanishi, John Meijer, Reiner Tretter, I Mohaćek, E. Marcel van Gelderen	2013	12
8	Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the In Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist Clinical Drug Investigation ·Jennifer Lee, Selina Moy, John Meijer, Walter Krauwinkel, Taiji Sawamoto, Shino Nakanishi, Donna Kowalski, Michael J. Roy, Noha Fawzy Fonon, Alexandre Vallet, Marcel van Gelderen, James J. Keirns	2013	23
9	The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol European Journal of Drug Metabolism and Pharmacokinetics ·Walter Krauwinkel, James Dickinson, Marloes Schaddelee, John Meijer, Reiner Tretter, Shivani Arsey, I Mohaćek, Marcel van Gelderen	2013	35
10	Absorption, Metabolism and Excretion of [14C]Mirabegron (YM178), a Potent and Selective β3-Adrenoceptor Agonist, after Oral Administration to Healthy Male Volunteers Drug Metabolism and Disposition ·Alexandre Vallet, Jan Jaap van Lier, Katsuhiro Suzuki, Masanori Nagata, John Meijer, Walter Krauwinkel, Marloes Schaddelee, Mitsuhiro Sekiguchi, Aiji Miyashita, Takafumi Iwatsubo, Marcel van Gelderen, Takashi Usui	2012	46
11	Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron Clinical Drug Investigation ·James Dickinson, María Fernanda Hourcade López, Taiji Sawamoto, Walter Krauwinkel, Marloes Schaddelee, James J. Keirns, Shino Nakanishi, Selina Moy, John Meijer, Donna Kowalski, Richard E. Morton, Kenneth C. Lasseter, Dennis Riff, Viera Kupčová, Marcel van Gelderen	2012	24
12	Development and validation of LC–MS/MS methods for the determination of mirabegron and its metabolites in human plasma and their application to a clinical pharmacokinetic study Journal of Chromatography B ·Giuliano Manera LONGHI, John Meijer, Alexandre Vallet, Marcel van Gelderen, Stephen H. F Dowall, Takashi Usui	2012	46
13	Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder International Journal of Clinical Pharmacology and Therapeutics ·Jørn Patrick Meyer, Jennifer Lee, Marloes Schaddelee, Wenhui Zhang, Shino Nakanishi, John Meijer, Sjoerd van Marle, Nicole Grunenberg, Donna Kowalski, Ted Drogendijk, Selina Moy, Lie-Injo Luan Eng, Marcel van Gelderen, Hiroshi Matsushima, Taiji Sawamoto	2012	42
14	Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women Clinical Therapeutics ·Walter Krauwinkel, Jan van Dijk, Marloes Schaddelee, Jørn Patrick Meyer, John Meijer, I Mohaćek, Sjoerd van Marle, Shino Nakanishi, Marcel van Gelderen	2012	71
15	Inflammatory Proteins in Plasma and the Risk of Dementia Archives of Neurology ·Marianne J. Engelhart, Mirjam I. Geerlings, John Meijer, Amanda J. Kiliaan, Annemieke Ruitenberg, John C. van Swieten, Theo Stijnen, Albert Hofman, (unknown), Monique M.B. Breteler	2004	6
16	Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline Dementia and Geriatric Cognitive Disorders ·Marianne J. Engelhart, Annemieke Ruitenberg, John Meijer, Amanda J. Kiliaan, John C. van Swieten, Albert Hofman, Jacqueline C.M. Witteman, Monique M.B. Breteler	2004	40
17	Inflammatory Proteins and Depression in the Elderly Epidemiology ·Henning Tiemeier, Albert Hofman, Myung Won Woo, Amanda J. Kiliaan, John Meijer, Monique M.B. Breteler	2003	176
18	Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion Brain Research ·Eszter Farkas, Martijn C. de Wilde, Amanda J. Kiliaan, John Meijer, Jan N. Keijser, Paul G.M. Luiten	2002	50
19	Vitamin E and depressive symptoms are not related. The Rotterdam Study Journal of Affective Disorders ·Henning Tiemeier, Albert Hofman, Amanda J. Kiliaan, John Meijer, Monique M.B. Breteler	2002	32
20	Markers of Inflammation and Cellular Adhesion Molecules in Relation to Insulin Resistance in Nondiabetic Elderly: The Rotterdam Study The Journal of Clinical Endocrinology & Metabolism ·A. Elisabeth Hak, Huibert A. P. Pols, Icha Silfia, John Meijer, Amanda J. Kiliaan, B. Lankes, Monique M.B. Breteler, Jacqueline C.M. Witteman	2001	149

About John Meijer

John Meijer is a scholar working on Urology, Endocrinology, Diabetes and Metabolism, Biological Psychiatry, Transplantation and Behavioral Neuroscience, having authored 29 papers that have together received 1.9k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (10 papers), Hormonal and reproductive studies (8 papers), Cardiovascular Syncope and Autonomic Disorders (5 papers), Urinary Tract Infections Management (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Alzheimer's disease research and treatments (2 papers) and Pelvic floor disorders treatments (2 papers). The work is most often cited by research in Biological Psychiatry (222 citations), Urology (267 citations), Neurology (279 citations), Behavioral Neuroscience (119 citations) and Rheumatology (375 citations). John Meijer has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include Amanda J. Kiliaan, Monique M.B. Breteler, Albert Hofman, Henning Tiemeier, Annemieke Ruitenberg, Marianne J. Engelhart, John C. van Swieten, Jacqueline C.M. Witteman, Theo Stijnen and Mirjam I. Geerlings. Their work appears in journals such as Bioanalysis, Brain Research, Journal of Affective Disorders, Therapeutic Drug Monitoring and Advances in Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact